GlassScriptPhysician profile
Douglas Arthur Dobecki
NPI 1346213329
$8,323.62
in general payments reported to CMS, 2019-2025
31 companies · $780 in 2025
The $780 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,191 · 2020: $805 · 2021: $1,323 · 2022: $910 · 2023: $1,755 · 2024: $1,559 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,094.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,936.70 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Infinion 16 |
| Collegium Pharmaceutical, INC. | $503.10 | 2019-2025 | Belbuca |
| Scilex Pharmaceuticals INC. | $410.29 | 2019-2024 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $330.43 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Spr Therapeutics, INC | $222.60 | 2023-2024 | Sprint Pns System |
| Arbor Pharmaceuticals, INC. | $216.31 | 2019-2021 | |
| Si-Bone, INC. | $201.62 | 2024 | |
| Biotronik Nro, INC. | $199.50 | 2025 | Prospera |
| Biodelivery Sciences International, INC. | $182.25 | 2019-2021 | |
| Nevro Corp. | $150.56 | 2019-2024 | Senza |
| Biohaven Pharmaceuticals, INC. | $119.72 | 2020-2021 | |
| Nalu Medical, INC. | $119.00 | 2021-2024 | Nalu Neurostimulation System |
| Pfizer INC. | $96.07 | 2020-2023 | |
| Abbott Laboratories | $87.18 | 2021-2023 | Prodigy |
| Curonix LLC | $65.21 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $57.82 | 2019 | |
| Redhill Biopharma INC. | $52.36 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $50.78 | 2023 | Horizant |
| Axonics, INC. | $41.52 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $36.78 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $32.83 | 2019-2020 | |
| Assertio Therapeutics, INC. | $31.97 | 2019 | |
| Zyla Life Sciences, INC. | $28.53 | 2020 | |
| Shionogi INC | $27.47 | 2019 | |
| Stratus Medical, LLC | $20.66 | 2023 | Nimbus |
| Vertos Medical, INC. | $19.07 | 2024 | Mild Device Kit |
| Vertiflex, INC. | $19.01 | 2019 | |
| Kaleo, INC. | $18.31 | 2019 | |
| Vertical Pharmaceuticals, LLC | $17.54 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.32 | 2019 | |
| Medtronic, INC. | $14.11 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Dobecki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.